Literature DB >> 9316912

Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal.

M J Albert1, N A Bhuiyan, K A Talukder, A S Faruque, S Nahar, S M Faruque, M Ansaruzzaman, M Rahman.   

Abstract

To find reasons for the recent decline of Vibrio cholerae O139 Bengal cholera in Bangladesh, phenotypic and genotypic changes in O139 isolates obtained from patients with cholera from 1993 to 1996 were studied. The isolates were tested for the presence of ctx and tcpA genes, hemagglutinin/protease (HA/P), capsule, D-mannose-sensitive hemagglutinin (MSHA), L-fucose-sensitive hemagglutinin (FSHA), tube test (tube) and CAMP test (CAMP) hemolytic activities, resistance to 2,4-diamino-6,7-diisopropyl pteridine (O/129) and trimethoprim-sulfamethoxazole (TMP-SMX), and genotype by pulsed-field gel electrophoresis (PFGE). All isolates possessed ctx and tcpA genes, HA/P, and a capsule. Most isolates were negative for FSHA, but although the majority of the isolates were positive for MSHA, no discernible trend in the activity was found during the study period. All early isolates were CAMP hemolysin positive and resistant to the vibriostatic compound O/129 and TMP-SMX, the two properties that could be used for the presumptive diagnosis of O139 cholera. However, subsequently, isolates that were CAMP hemolysin negative and susceptible to TMP-SMX and O/129 were increasingly encountered, with all the 1996 isolates being so, which suggested that these properties can no longer be used for the presumptive diagnosis of O139 cholera. V. cholerae O139 isolates that were CAMP hemolysin positive and resistant to O/129 and TMP-SMX produced a disease of greater severity than that caused by the CAMP hemolysin-negative and susceptible isolates on the basis of the lengths of stay of the hospitalized patients. The study period witnessed the evolution of four different genotypes by PFGE. All of these data suggested that the V. cholerae O139 isolates have undergone changes in some properties. However, how these changes influenced their prevalence relative to that of V. cholerae O1 in human infection is not clear. Studies of the environmental factors will provide the key for an understanding of the relative abundance of these vibrios.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316912      PMCID: PMC230015          DOI: 10.1128/jcm.35.10.2588-2592.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.

Authors:  P A Sokol; D E Ohman; B H Iglewski
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

2.  Expression and detection of different biotype-associated cell-bound haemagglutinins of Vibrio cholerae O1.

Authors:  G Jonson; J Sanchez; A M Svennerholm
Journal:  J Gen Microbiol       Date:  1989-01

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

Authors:  T Ramamurthy; S Garg; R Sharma; S K Bhattacharya; G B Nair; T Shimada; T Takeda; T Karasawa; H Kurazano; A Pal
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

5.  Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited.

Authors:  R A Finkelstein; M Boesman-Finkelstein; P Holt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

6.  Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains of Vibrio cholerae from clinical cases of cholera in Calcutta, India.

Authors:  T Ramamurthy; A Pal; S C Pal; G B Nair
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

7.  Genetic basis of trimethoprim and O/129 resistance in Vibrio cholerae.

Authors:  G Gerbaud; A Dodin; F Goldstein; P Courvalin
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1985 Nov-Dec

8.  Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar 01 associated with live copepods in laboratory microcosms.

Authors:  A Huq; P A West; E B Small; M I Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

9.  Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment.

Authors:  R A Finkelstein; M Boesman-Finkelstein; Y Chang; C C Häse
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic.

Authors:  T J Barrett; P A Blake
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

View more
  10 in total

1.  Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh.

Authors:  S M Faruque; A K Siddique; M N Saha; M M Rahman; K Zaman; M J Albert; D A Sack; R B Sack
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal.

Authors:  K A Talukder; B K Khajanchi; M A Islam; D K Dutta; Z Islam; S I Khan; G B Nair; D A Sack
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

3.  Ecological diversification of Vibrio fischeri serially passaged for 500 generations in novel squid host Euprymna tasmanica.

Authors:  William Soto; Ferdinand M Rivera; Michele K Nishiguchi
Journal:  Microb Ecol       Date:  2014-01-09       Impact factor: 4.552

4.  Competence and natural transformation in vibrios.

Authors:  Yan Sun; Eryn E Bernardy; Brian K Hammer; Tim Miyashiro
Journal:  Mol Microbiol       Date:  2013-07-15       Impact factor: 3.501

5.  Genetic diversity of clinical and environmental isolates of Vibrio cholerae determined by amplified fragment length polymorphism fingerprinting.

Authors:  S C Jiang; M Matte; G Matte; A Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

6.  Vibrio cholerae virulence regulator-coordinated evasion of host immunity.

Authors:  Ansel Hsiao; Zhi Liu; Adam Joelsson; Jun Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Prevalence of pandemic thermostable direct hemolysin-producing Vibrio parahaemolyticus O3:K6 in seafood and the coastal environment in Japan.

Authors:  Yukiko Hara-Kudo; Kanji Sugiyama; Mitsuaki Nishibuchi; Ashrafuzzaman Chowdhury; Jun Yatsuyanagi; Yoshimitsu Ohtomo; Akinobu Saito; Hidetoshi Nagano; Tokuhiro Nishina; Hiroshi Nakagawa; Hirotaka Konuma; Michiko Miyahara; Susumu Kumagai
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

8.  Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in Bangladesh.

Authors:  Kaisar A Talukder; Zhahirul Islam; M Aminul Islam; Dilip K Dutta; Ashrafus Safa; M Ansaruzzaman; A S G Faruque; Shamima N Shahed; G B Nair; David A Sack
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh.

Authors:  Kaisar A Talukder; M Aminul Islam; Dilip K Dutta; Ferdaus Hassan; Ashrafus Safa; G B Nair; David A Sack
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Isolation, characterization, and antibiotic resistance of Vibrio spp. in sea turtles from Northwestern Mexico.

Authors:  Alan A Zavala-Norzagaray; A Alonso Aguirre; Jorge Velazquez-Roman; Héctor Flores-Villaseñor; Nidia León-Sicairos; C P Ley-Quiñonez; Lucio De Jesús Hernández-Díaz; Adrian Canizalez-Roman
Journal:  Front Microbiol       Date:  2015-06-25       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.